Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000687462 | SCV000815027 | pathogenic | Congenital myasthenic syndrome 4A | 2024-01-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro265Argfs*35) in the CHRNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHRNE are known to be pathogenic (PMID: 22678886). This variant is present in population databases (rs756675414, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. ClinVar contains an entry for this variant (Variation ID: 567393). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV001784311 | SCV002019304 | pathogenic | not provided | 2019-10-09 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000687462 | SCV004212599 | pathogenic | Congenital myasthenic syndrome 4A | 2024-01-26 | criteria provided, single submitter | clinical testing |